These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors. Everett RS; Hodges BL; Ding EY; Xu F; Serra D; Amalfitano A Hum Gene Ther; 2003 Dec; 14(18):1715-26. PubMed ID: 14670123 [TBL] [Abstract][Full Text] [Related]
5. Adenovirus gene transfer vectors inhibit growth of lymphatic tumor metastases independent of a therapeutic transgene. Korst RJ; Ailawadi M; Lee JM; Lee S; Yamada R; Mahtabifard A; Crystal RG Hum Gene Ther; 2001 Sep; 12(13):1639-49. PubMed ID: 11535167 [TBL] [Abstract][Full Text] [Related]
6. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract. Worgall S; Leopold PL; Wolff G; Ferris B; Van Roijen N; Crystal RG Hum Gene Ther; 1997 Sep; 8(14):1675-84. PubMed ID: 9322870 [TBL] [Abstract][Full Text] [Related]
7. Viral IL-10 gene transfer inhibits DTH responses to soluble antigens: evidence for involvement of genetically modified dendritic cells and macrophages. Whalen JD; Thomson AW; Lu L; Robbins PD; Evans CH Mol Ther; 2001 Dec; 4(6):543-50. PubMed ID: 11735338 [TBL] [Abstract][Full Text] [Related]
8. Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxide. Lasarte JJ; Corrales FJ; Casares N; López-Díaz de Cerio A; Qian C; Xie X; Borrás-Cuesta F; Prieto J J Immunol; 1999 May; 162(9):5270-7. PubMed ID: 10228002 [TBL] [Abstract][Full Text] [Related]
9. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039 [TBL] [Abstract][Full Text] [Related]
10. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Zsengeller ZK; Wert SE; Hull WM; Hu X; Yei S; Trapnell BC; Whitsett JA Hum Gene Ther; 1995 Apr; 6(4):457-67. PubMed ID: 7612702 [TBL] [Abstract][Full Text] [Related]
11. Strain-specific rate of shutdown of CMV enhancer activity in murine liver confirmed by use of persistent [E1(-), E2b(-)] adenoviral vectors. Everett RS; Evans HK; Hodges BL; Ding EY; Serra DM; Amalfitano A Virology; 2004 Jul; 325(1):96-105. PubMed ID: 15231389 [TBL] [Abstract][Full Text] [Related]
12. Immune response to syngeneic or autologous testicular cells in mice. I. Augmented delayed footpad reaction in cyclophosphamide-treated mice. Yoshida S; Nomoto K; Himeno K; Takeya K Clin Exp Immunol; 1979 Nov; 38(2):211-7. PubMed ID: 527259 [TBL] [Abstract][Full Text] [Related]
13. Auto-delayed-type hypersensitivity induced in immunodeficient mice with modified self-antigens. V. Cellular autoreactivity directed against self-H-2Dd subregion mediates the inflammatory responses. Tarcic N; David CS; Naor D Immunology; 1989 Jun; 67(2):184-90. PubMed ID: 2502495 [TBL] [Abstract][Full Text] [Related]
14. Establishment and comparison of delayed-type hypersensitivity models in the B₆C₃F₁ mouse. Smith MJ; White KL J Immunotoxicol; 2010; 7(4):308-17. PubMed ID: 20825253 [TBL] [Abstract][Full Text] [Related]
15. Local immune response to Mycobacterium lepraemurium in C3H and C57Bl/6 mice. Lagrange PH; Hurtrel B Clin Exp Immunol; 1979 Dec; 38(3):461-74. PubMed ID: 394891 [TBL] [Abstract][Full Text] [Related]
16. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3. Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a novel delayed-type hypersensitivity assay to Candida albicans in adult and neonatal rats. Thorn M; Hudson AW; Kreeger J; Kawabe TT; Bowman CJ; Collinge M J Immunotoxicol; 2015; 12(4):350-60. PubMed ID: 25412622 [TBL] [Abstract][Full Text] [Related]
18. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain. Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961 [TBL] [Abstract][Full Text] [Related]
19. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Worgall S; Wolff G; Falck-Pedersen E; Crystal RG Hum Gene Ther; 1997 Jan; 8(1):37-44. PubMed ID: 8989993 [TBL] [Abstract][Full Text] [Related]
20. Induction and characterization of delayed-type hypersensitivity to dengue virus in mice. Pang T; Wong PY; Pathmanathan R J Infect Dis; 1982 Aug; 146(2):235-42. PubMed ID: 7108274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]